Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain

Radiology

Volumn 232, Issue 3, 2004, Pages 867-873

  Mascalchi, Mario ^a   Lolli, Francesco ^a   Della Nave, Riccardo ^a   Tessa, Carlo ^a   Petralli, Raffaele ^a   Gavazzi, Cinzia ^a   Politi, Letterio S ^a   Macucci, Marco ^b   Filippi, Massimo ^c   Placentini, Silvia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Unit of Neurophysiopathology   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Brain, diffusion; Brain, diseases; Brain, MR; Huntington disease; Magnetic resonance (MR), diffusion tensor; Magnetic resonance (MR), magnetization transfer

Indexed keywords

HALOPERIDOL;

ADULT; AGED; ARTICLE; BRAIN DISEASE; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; GENE MUTATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; STATISTICAL ANALYSIS; WHITE MATTER;

ADULT; AGED; BRAIN; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 4143085873     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2322030820     Document Type: Article

References (39)

1. Martin JB. Molecular basis of the neurodegenerative disorders. N Engl J Med 1999; 340:1970-1980.
2. Harris GJ, Pearlson GD, Peyser CE, et al. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol 1992; 31:69-75.
3. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene of Huntington's disease in asymptomatic at-risk persons. Neurology 1994; 44:823-828.
4. Rosas HD, Goodman J, Chen YI, et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 2001; 57:1025-1028.
5. Aylward EH, Codori AM, Rosenblatt A, et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000; 15: 552-560.
6. Hanyu H, Asano T, Iwamoto T, Takasaki M, Shindo H, Abe K. Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. AJNR Am J Neuroradiol 2000; 21: 1235-1242.
7. Hanyu H, Asano T, Sakurai H, Takasaki N, Shindo H, Abe K. Magnetization transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 2001; 43:542-546.
8. Bozzali M, Franceschi M, Falini A, et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001; 57:1135-1137.
9. Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K. Diffusion-weighted MR imaging of the hippocampus and temporal lobe white matter in Alzheimer's disease. J Neurol Sci 1998; 156:195-200.
10. Rose SE, Chen F, Chalk JB, et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2000; 69:528-530.
11. Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002; 72:742-746.
12. Muglia M, Leone O, Annesi G, et al. Nonisotopic method for accurate detection of (CAG)n repeats causing Huntington disease. Clin Chem 1996; 42:1601-1603.
13. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996; 59:16-22.
14. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979; 29:1-3.
15. Shoulson I. Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981; 31:1333-1335.
16. Smith S. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17:143-145.
17. Mascalchi M, Tessa C, Moretti M, et al. Whole brain apparent diffusion coefficient histogram: a new tool for evaluation of leukoaraiosis. J Magn Reson Imaging 2002; 15:144-148.
18. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000; 12:191-200.
19. Gunning-Dixon FM, Head D, McQuain J, Acker JD, Raz N. Differential aging of the human striatum: a prospective MR imaging study. AJNR Am J Neuroradiol 1998; 19:1501-1507.
20. Engelter ST, Provenzale JM, Petrella JR, DeLong DM, MacFall JR. The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. AJR Am J Roentgenol 2000; 175:425-430.
21. Nusbaum AO, Tang CY, Buchsbaum MS, Wei TC, Atlas SW. Regional and global changes in cerebral diffusion with normal aging. AJNR Am J Neuroradiol 2001; 22:136-142.
22. Chen ZG, Li TQ, Hindmarsh T. Diffusion tensor trace mapping in normal adult brain using single-shot EP1 technique. Acta Radiol 2001; 42:447-458.
23. Peterson BS, Riddle MA, Cohen DJ, et al. Human basal ganglia volume asymmetries on magnetic resonance images. Magn Reson Imaging 1993; 11:493-498.
24. Ifthikharuddin SF, Shrier DA, Numaguchi Y, et al. MR volumetric analysis of the human basal ganglia: normative data. Acad Radiol 2000; 7:627-634.
25. Szabò CA, Lancaster JL, Xiong J, Cook C, Fox P. MR imaging volumetry of subcortical structures and cerebellar hemispheres in normal persons. AJNR Am J Neuroradiol 2003; 24:644-647.
26. Thieben MJ, Duggins AJ, Good CD, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125:1815-1828.
27. Cercignani M, Iannucci G, Rocca MA, Comi G, Horsfield MA, Filippi M. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 2000; 54:1139-1144.
28. Adams RD, Victor M, eds. Principles of neurology. 3rd ed. New York, NY: McGraw-Hill, 1985; 859-901.
29. Ross CA. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002; 35:819-822.
30. Chun T, Filippi CG, Zimmerman RD, Ulug AM. Diffusion changes in the aging human brain. AJNR Am J Neuroradiol 2000; 21:1078-1083.
31. Helenius J, Soinne L, Perkio J, et al. Diffusion-weighted MR imaging in normal humans brains in various age groups. AJNR Am J Neuroradiol 2002; 23:194-199.
32. Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002; 58:695-701.
33. Sieradzan KA, Mann DMA. The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol 2001; 27:1-21.
34. Gass A, Niendorf T, Hirsch JG. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders: biophysical mechanisms and possible underlying pathology. J Neurol Sci 2001; 186(suppl):S15-S23.
35. Inglese M, Rovaris M, Bianchi S, et al. Magnetic resonance imaging, magnetization transfer imaging and diffusion-weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001; 70: 444-449.
36. Ferini-Strambi L, Bozzali M, Cercignani M, et al. Magnetization transfer and diffusion-weighted imaging in nocturnal frontal lobe epilepsy. Neurology 2000; 54:2331-2333.
37. Yamamoto A, Lucas JJ, Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000; 101:57-66.
38. Verhagen Metman L, Morris MJ, Farmer C, et al. Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine. Neurology 2002; 59:694-699.
39. Hauser RA, Furtado S, Cimino CR, et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002; 58:687-695.